Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach
Journal Title: Journal of Addiction Medicine and Therapeutic Science - Year 2016, Vol 2, Issue 1
Abstract
Background: Methamphetamine abuse and dependence is currently a considerable problem. Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving. Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving. Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature. Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.
Authors and Affiliations
Ahmadi Jamshid
Keywords
Related Articles
- EP ID EP322736
- DOI 10.17352/2455-3484.000011
- Views 106
- Downloads 0
The Opioid Epidemic: Can We Reverse The Historical Trend?
Opium derived from the condensed juice of the poppy, Papaver Somniferum, has been used as an analgesic, euphoric, and soporific for centuries. The use of opium use goes back 6000 years to China. It was initially cultivat...
Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
Background: Since its U.S. FDA approval in 2002, buprenorphine has been available for maintenance treatment of opiate dependence in primary care physicians’ offices. Though buprenorphine was intended to facilitate access...
The Effects of Beverage Specific Alcohol Sale on Liver Cirrhosis Mortality in Russia
Background: Liver cirrhosis is a major cause of deaths in many developed countries. There is evidence that beverage preference may have modifying influence on liver cirrhosis risk independently of the amount of alcohol c...
Unrecorded Alcohol Consumption among Alcohol Dependent Patients
Introduction: Experts estimate that unrecorded alcohol makes up a significant share (about 25%) of all alcohol consumed in the former Soviet Republic Belarus. However, our knowledge with respect to the prevalence of the...
Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of many anticancer drugs such as platinum compounds, antitubulins (taxanes and vinca alkaloids), bortezomib and thalidomide [1]. CIPN may manifest...